Acute heart failure: is there a role for surgery?

A. A. Pitsis1, C. E. Anagnostopoulos2,3
1Thessaloniki Heart Institute, St. Luke’s Hospital, Panorama, Thessaloniki, Greece
2Department of Cardiac Surgery, University of Athens School of Medicine, Athens University Hospital Attikon, Athens, Greece
3Department of Cardiac Surgery, St. Luke’s and Roosevelt Hospital Center, Columbia University, New York, USA

Tóm tắt

Many of the disorders and lesions leading to acute heart failure can be treated surgically. Modern surgical techniques like the off pump coronary surgery, newer techniques for the surgical treatment of the mechanical complications of acute MI and valvular reparative techniques have been added to the surgical armamentarium in recent years. Modern ventricular assist devices have started their career in the clinical arena promising to be less invasive. At the same time the spectrum of indications for mechanical circulatory support continues to witness a rapid expansion. Technical advances have led to an evolution of surgical strategies. Heart failure surgery is now in a position to offer improved outcomes, avoidance of recurrence of acute heart failure or the development of advanced chronic heart failure.

Từ khóa


Tài liệu tham khảo

Braunwald E (2006) Atlas of heart failure, 4th edn, Current Medicine Group, London, UK

Nieminen MS, Bohm M, Cowie MR, Drexler H, Filippatos GS, Jondeau G, Hasin Y, Lopez-Sendon J, Mebazaa A, Metra M, Rhodes A, Swedberg K, Priori SG, Garcia MA, Blanc JJ, Budaj A, Cowie MR, Dean V, Deckers J, Burgos EF, Lekakis J, Lindahl B, Mazzotta G, Morais J, Oto A, Smiseth OA, Garcia MA, Dickstein K, Albuquerque A, Conthe P, Crespo-Leiro M, Ferrari R, Follath F, Gavazzi A, Janssens U, Komajda M, Morais J, Moreno R, Singer M, Singh S, Tendera M, Thygesen K (2005) ESC Committee for Practice Guideline (CPG). Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: the task force on acute heart failure of the European Society of cardiology. Eur Heart J 26(4):384–416

Eagle KA, Guyton RA,Davidoff R, Edwards FH, Ewy GA, Gardner TJ, Hart JC, Herrmann HC, Hillis LD, Hutter AM Jr, Lytle BW, Marlow RA, Nugent WC, Orszulak TA (2004) ACC/AHA 2004 guideline update for coronary artery bypass graft surgery: a report of the American College of Cardiology/American Heart Association. Circulation 110:340–437

FitzGibbon GM, Leach AJ, Kafka HP (1987) Atherosclerosis of coronary artery bypass grafts and smoking. CMAJ 136:45–47

von Segesser LK, Popp J, Amann FW, Turina MI (1994) Surgical revas-cularization in acute myocardial infarction. Eur J Cardiothorac Surg 8:363–368

Fremes SE, Goldman BS, Christakis GT et al (1991) Current risk of coronary bypass for unstable angina. Eur J Cardiothorac Surg 5:235–242

Braxton JH, Hammond GL, Letsou GV et al (1995) Optimal timing of coronary artery bypass graft surgery after acute myocardial infarction. Circulation 92(Suppl II):66–68

The clopidogrel in unstable angina to prevent recurrent events trial investigators (2001) Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345:494–502

Khot UN, Nissen SE (2002) Is CURE a cure for acute coronary syndromes? Statistical versus clinical significance. J Am Coll Cardiol 40:218–219

Hongo R, Ley J, Dick S et al (2002) The effect of clopidogrel in combination with aspirin when given before coronary artery bypass grafting. J Am Coll Cardiol 40:231–237

Clark SC, Vitale N, Zacharias J, Forty J (2000) Effect of low molecular weight heparin (fragmin) on bleeding after cardiac surgery. Ann Thorac Surg 69:762–764

Lincoff AM, LeNarz LA, Despotis GJ et al (2000) Abciximab and bleeding during coronary surgery: results from the EPILOG and EPISTENT trials. Improve Long-term Outcome with abciximab GP IIb/IIIa blockade. Evaluation of Platelet IIb/IIIa Inhibition in STENTing. Ann Thorac Surg 70:516–526

Singh M, Nuttall GA, Ballman KV et al (2001) Effect of abciximab on the outcome of emergency coronary artery bypass grafting after failed percutaneous coronary intervention. Mayo Clin Proc 76:784–788

Ascione R, Williams S, Lloyd CT, Sundaramoorthi T, Pitsis AA, Angelini GD (2001) Reduced postoperative blood loss and transfusion requirement after beating-heart coronary operations. a prospective randomized study. J Thorac Cardiovasc Surg 121:689–696

Stevenson WG, Linssen GCM, Havenith MG et al (1989) The spectrum of death after myocardial infarction: a necropsy study. Am Heart J 118:1182

Agnihotri AK, Madsen JC, Daggett WM Jr (2003) Surgical treatment of complications of acute myocardial infarction: postinfarction ventricular septal defect and free wall rupture. In: Cohn LH, Edmunds LH Jr (eds) Cardiac surgery in the adult. McGraw-Hill, New York, pp 681–714

Park WM, Connery CP, Hochman JS, Tilson MD, Anagnostopoulos CE (2000) Successful repair of myocardial free wall rupture after thrombolytic therapy for acute infarction. Ann Thorac Surg 70(4):1345–1349

Anagnostopoulos CE, Beutler S, Levett JM, Lawrence JM, Lin CY, Replogle RL (1977) Myocardial rupture. JAMA 238:2715–2716

David TE, Dale L, Sun Z (1995) Postinfarction ventricular septal rupture: repair by endocardial patch with infarct exclusion. J Thorac Cardiovasc Surg 110:1315–1322

Kshettry V, Salerno C, Bank A (1997) Risk of left ventricular assist device as a bridge to heart transplant following postinfarction ventricular septal rupture. J Card Surg 12:93

Meyns B, Vanermen H, Vanhaecke J et al (1994) Hemopump fails as bridge to transplantation in postinfarction ventricular septal defect. J Heart Lung Transplant 13:1133

Gorman RC, Gorman JH III, Edmunds LH Jr (2003) Ischemic mitral regurgitation. In: Cohn LH, Edmunds LH Jr (eds) Cardiac surgery in the adult. New York: McGraw-Hill, pp 751–769

Pitsis AA, Dardas P, Mezilis N, Nikoloudakis N, Filippatos G, Burkhoff D (2004) Temporary assist device for postcardiotomy heart failure. Ann Thorac Surg 77:1431–1433

Rose EA, Gelijns AC, Moskowitz AJ et al (2001) For the randomized evaluation of mechanical assistance for the treatment of congestive heart failure (REMATCH) study group. Long-term use of a left ventricular assist device for end-stage heart failure. N Engl J Med 345:1435–1443

Pitsis AA, Visouli AN, Vassilikos V et al (2006) First human implantation of a new rotary blood pump: design of the clinical feasibility study. Hellenic J Cardiol 47:368–376

Birks EJ, Tansley PD, Hardy J, George RS, Bowles CT, Burke M, Banner NR, Khaghani A, Yacoub MH (2006) Left ventricular assist device and drug therapy for the reversal of heart failure. N Engl J Med 355(18):1873–1884